AF
DGX icon

Aviso Financial’s Quest Diagnostics DGX Stock Holding History

Aviso Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
489
+269
+122% +$52.8K ﹤0.01% 222
2026
Q1 		$43.1K Buy
220
+178
+424% +$34.6K ﹤0.01% 252
2025
Q4 		$7.29K Buy
+42
New +$7.65K ﹤0.01% 289

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Aviso Financial's DGX Position: Q2 2026 in Review

Aviso Financial increased its Quest Diagnostics (DGX) stake by 122% in Q2 2026, buying an estimated $52.8K and bringing the position to 489 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #222.

Aviso Financial first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Aviso Financial held 489 shares of Quest Diagnostics worth $104K as of Q2 2026.
  • Aviso Financial bought 269 Quest Diagnostics shares in Q2 2026, an estimated $52.8K.
  • Quest Diagnostics made up ﹤0.01% of Aviso Financial's portfolio in Q2 2026, its #222 holding.
  • Aviso Financial first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.